Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
|
JAMA
|
2004
|
15.34
|
2
|
The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
|
Arch Gen Psychiatry
|
2007
|
3.78
|
3
|
Building a virtual cancer research organization.
|
J Natl Cancer Inst Monogr
|
2005
|
3.60
|
4
|
Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).
|
J Am Acad Child Adolesc Psychiatry
|
2006
|
2.95
|
5
|
The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial.
|
J Am Acad Child Adolesc Psychiatry
|
2009
|
2.13
|
6
|
Recovery and recurrence following treatment for adolescent major depression.
|
Arch Gen Psychiatry
|
2010
|
1.89
|
7
|
Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability.
|
J Am Acad Child Adolesc Psychiatry
|
2009
|
1.85
|
8
|
Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence.
|
J Allergy Clin Immunol
|
2007
|
1.67
|
9
|
The services for children and adolescents-parent interview: development and performance characteristics.
|
J Am Acad Child Adolesc Psychiatry
|
2004
|
1.64
|
10
|
Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma.
|
J Allergy Clin Immunol
|
2010
|
1.57
|
11
|
Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence.
|
J Allergy Clin Immunol
|
2011
|
1.56
|
12
|
AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology.
|
J Am Acad Child Adolesc Psychiatry
|
2004
|
1.53
|
13
|
Observed classroom behavior of children with ADHD: relationship to gender and comorbidity.
|
J Abnorm Child Psychol
|
2002
|
1.45
|
14
|
Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study.
|
J Am Acad Child Adolesc Psychiatry
|
2009
|
1.44
|
15
|
Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).
|
J Am Acad Child Adolesc Psychiatry
|
2006
|
1.38
|
16
|
Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection.
|
Hepatology
|
2007
|
1.38
|
17
|
Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus.
|
J Clin Endocrinol Metab
|
2010
|
1.36
|
18
|
Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroids.
|
J Allergy Clin Immunol
|
2006
|
1.36
|
19
|
Assessing medication effects in the MTA study using neuropsychological outcomes.
|
J Child Psychol Psychiatry
|
2006
|
1.34
|
20
|
Dissemination of the Coping Power program: importance of intensity of counselor training.
|
J Consult Clin Psychol
|
2009
|
1.32
|
21
|
Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells.
|
Glia
|
2006
|
1.28
|
22
|
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary.
|
J Atten Disord
|
2008
|
1.27
|
23
|
Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.
|
Am J Psychiatry
|
2005
|
1.26
|
24
|
The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.
|
Am J Psychiatry
|
2009
|
1.24
|
25
|
Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach.
|
Pharm Stat
|
2014
|
1.24
|
26
|
Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.
|
Am J Psychiatry
|
2012
|
1.18
|
27
|
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details.
|
J Atten Disord
|
2008
|
1.18
|
28
|
Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.
|
Pharmacoepidemiol Drug Saf
|
2009
|
1.18
|
29
|
A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma.
|
J Allergy Clin Immunol
|
2010
|
1.16
|
30
|
Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy.
|
Am Heart J
|
2006
|
1.12
|
31
|
Onset of alcohol or substance use disorders following treatment for adolescent depression.
|
J Consult Clin Psychol
|
2012
|
1.10
|
32
|
Negative emotions and alcohol use initiation in high-risk boys: the moderating effect of good inhibitory control.
|
J Abnorm Child Psychol
|
2004
|
1.10
|
33
|
Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications?
|
Med Care
|
2006
|
1.04
|
34
|
Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations.
|
Ann Allergy Asthma Immunol
|
2008
|
1.04
|
35
|
Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in the Multimodal Treatment Study of Children With ADHD: developmental cascades and vicious cycles.
|
Dev Psychopathol
|
2010
|
1.00
|
36
|
A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA).
|
Curr Psychiatry Rep
|
2008
|
0.96
|
37
|
Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers.
|
Clin Gastroenterol Hepatol
|
2007
|
0.96
|
38
|
Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients.
|
J Allergy Clin Immunol
|
2010
|
0.94
|
39
|
Impact of bipolar disorder: results from a screening study.
|
Prim Care Companion J Clin Psychiatry
|
2007
|
0.92
|
40
|
Relation of worsened renal function during hospitalization for heart failure to long-term outcomes and rehospitalization.
|
Am J Cardiol
|
2011
|
0.91
|
41
|
The clinical history and costs associated with delayed diagnosis of bipolar disorder.
|
MedGenMed
|
2006
|
0.90
|
42
|
Colon polyp recurrence in a managed care population.
|
Arch Intern Med
|
2003
|
0.88
|
43
|
Epidemiologic study of aripiprazole use and the incidence of suicide events.
|
Pharmacoepidemiol Drug Saf
|
2010
|
0.85
|
44
|
Bipolar disorder detection, ascertainment, and treatment: primary care physician knowledge, attitudes, and awareness.
|
Prim Care Companion J Clin Psychiatry
|
2006
|
0.84
|
45
|
Comparison of renal predictors for in-hospital and postdischarge mortality after hospitalized heart failure.
|
J Cardiovasc Med (Hagerstown)
|
2012
|
0.79
|
46
|
ACTH-secreting islet cell tumor of the pancreas presenting as bilateral ovarian tumors and Cushing's syndrome.
|
Int J Gynecol Pathol
|
2002
|
0.79
|
47
|
Invite yourself to the table: librarian contributions to the electronic medical record.
|
Med Ref Serv Q
|
2013
|
0.79
|
48
|
The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapy.
|
Pharmacoepidemiol Drug Saf
|
2006
|
0.78
|
49
|
Relationship of Loop Diuretic Dosing and Acute Changes in Renal Function during Hospitalization for Heart Failure.
|
J Clin Exp Cardiolog
|
2011
|
0.77
|
50
|
Comparison of β-blocker effectiveness in heart failure patients with preserved ejection fraction versus those with reduced ejection fraction.
|
J Card Fail
|
2013
|
0.77
|
51
|
Patient characteristics and participation in a genetic study: a type 2 diabetes cohort.
|
J Investig Med
|
2014
|
0.75
|
52
|
Race and association of angiotensin converting enzyme/angiotensin receptor blocker exposure with outcome in heart failure.
|
J Cardiovasc Med (Hagerstown)
|
2015
|
0.75
|
53
|
Total laparoscopic hysterectomy using multifunction grasping, coagulating, and cutting forceps.
|
J Laparoendosc Adv Surg Tech A
|
2004
|
0.75
|